Axon Enterprise, Inc. (NASDAQ:AXON) Shares Bought by PFG Investments LLC

PFG Investments LLC lifted its position in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 0.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 3,872 shares of the biotechnology company’s stock after acquiring an additional 25 shares during the period. PFG Investments LLC’s holdings in Axon Enterprise were worth $1,547,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of AXON. Mather Group LLC. increased its stake in shares of Axon Enterprise by 3.7% in the third quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after purchasing an additional 27 shares during the period. CWM LLC increased its position in Axon Enterprise by 1.3% in the 3rd quarter. CWM LLC now owns 2,856 shares of the biotechnology company’s stock valued at $1,141,000 after acquiring an additional 36 shares during the period. SPC Financial Inc. raised its stake in Axon Enterprise by 2.2% during the 3rd quarter. SPC Financial Inc. now owns 1,773 shares of the biotechnology company’s stock valued at $708,000 after acquiring an additional 38 shares in the last quarter. Dorsey Wright & Associates raised its stake in Axon Enterprise by 0.3% during the 2nd quarter. Dorsey Wright & Associates now owns 14,053 shares of the biotechnology company’s stock valued at $4,135,000 after acquiring an additional 39 shares in the last quarter. Finally, Legacy Capital Group California Inc. boosted its position in Axon Enterprise by 5.7% during the 3rd quarter. Legacy Capital Group California Inc. now owns 724 shares of the biotechnology company’s stock worth $289,000 after acquiring an additional 39 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on AXON shares. Barclays raised their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. The Goldman Sachs Group boosted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday. Bank of America began coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective for the company. Northland Securities boosted their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Finally, Needham & Company LLC increased their price target on Axon Enterprise from $400.00 to $525.00 and gave the company a “buy” rating in a research note on Tuesday, October 22nd. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $382.85.

View Our Latest Report on AXON

Insider Buying and Selling

In other Axon Enterprise news, President Joshua Isner sold 25,811 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the transaction, the president now directly owns 228,166 shares in the company, valued at approximately $82,103,253.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $437.98, for a total value of $437,980.00. Following the completion of the sale, the director now directly owns 26,259 shares of the company’s stock, valued at $11,500,916.82. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, President Joshua Isner sold 25,811 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the transaction, the president now directly owns 228,166 shares in the company, valued at $82,103,253.44. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 371,172 shares of company stock valued at $137,000,162. Company insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Up 0.3 %

Shares of Axon Enterprise stock opened at $444.52 on Friday. The stock’s fifty day moving average is $396.09 and its 200-day moving average is $336.52. The firm has a market capitalization of $33.55 billion, a PE ratio of 129.98, a price-to-earnings-growth ratio of 12.05 and a beta of 0.94. Axon Enterprise, Inc. has a 12-month low of $199.29 and a 12-month high of $455.17. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.18. The firm had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business’s revenue for the quarter was up 34.5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.80 EPS. Equities analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Featured Stories

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.